Public record
Trulicity: the public record
Each table is computed from the named federal dataset as of its data date; the method is under each one.
Medicaid
Medicaid prescriptions for Trulicity by state
State Medicaid programmes paid for 1,939,514 Trulicity prescriptions in 2025, with $1.95B reimbursed before rebates. Ohio reported the most (359,093), followed by Illinois (178,820) and California (127,774); 51 states and territories reported any.
| Measure | Value | Note |
|---|---|---|
| Prescriptions paid by Medicaid, 2025 | 1,939,514 | |
| Total reimbursed before rebates, 2025 | $1.95B | |
| States and territories reporting | 51 | with at least one count CMS did not suppress |
| Ohio | 359,093 prescriptions | $342.4M reimbursed |
| Illinois | 178,820 prescriptions | $192.1M reimbursed |
| California | 127,774 prescriptions | $124.1M reimbursed |
| Virginia | 115,903 prescriptions | $113.5M reimbursed |
| Pennsylvania | 110,864 prescriptions | $112.6M reimbursed |
How this was calculated
Matched each Medicaid product code to the FDA NDC Directory by labeler and product code, kept finished single-ingredient products, then summed prescriptions and reimbursement by state. National roll-up and suppressed rows dropped.
Trulicity only (brand-name dulaglutide), fee-for-service and managed care, 2025
Counts under 11 are suppressed by CMS and left out, so totals are a floor. Amounts are before rebates. Differences between states reflect programme size and coverage rules. Compounded products are not included.